Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa”

456 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 456 results

Post-approval studies (Phase 4)Study completedNCT05312632
What this trial is testing

Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea

Who this might be right for
Parkinson Disease
Eisai Korea Inc. 201
Testing effectiveness (Phase 2)Study completedNCT00888004
What this trial is testing

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

Who this might be right for
Parkinson's DiseaseL-dopa Induced Dyskinesia
Novartis 28
Post-approval studies (Phase 4)Study completedNCT01494532
What this trial is testing

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

Who this might be right for
Parkinson Disease
GlaxoSmithKline 352
Post-approval studies (Phase 4)Study completedNCT04821687
What this trial is testing

Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD

Who this might be right for
Parkinson Disease
SK Chemicals Co., Ltd. 169
Testing effectiveness (Phase 2)Study completedNCT03197493
What this trial is testing

Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macula; DegenerationRetina
Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableNot Yet RecruitingNCT07405268
What this trial is testing

Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)PeriodontitisPeriodontal Diseases
Saglik Bilimleri Universitesi 136
Large-scale testing (Phase 3)Study completedNCT00466167
What this trial is testing

Pivotal Study in Advanced Parkinsons Disease Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 517
Early research (Phase 1)Study completedNCT00829439
What this trial is testing

Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome

Who this might be right for
Angelman Syndrome
Boston Children's Hospital 16
Not applicableWithdrawnNCT01218919
What this trial is testing

Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study

Who this might be right for
Parkinson Disease
Abbott Medical Devices
Large-scale testing (Phase 3)Study completedNCT00357994
What this trial is testing

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Who this might be right for
Advanced Parkinson's Disease
AbbVie (prior sponsor, Abbott) 36
Early research (Phase 1)Study completedNCT01484990
What this trial is testing

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

Who this might be right for
Parkinson Disease
AbbVie 19
Testing effectiveness (Phase 2)Study completedNCT03103399
What this trial is testing

Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 254
Post-approval studies (Phase 4)Looking for participantsNCT06765668
What this trial is testing

CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Who this might be right for
Parkinson Disease
Impax Laboratories, LLC 220
Not applicableStudy completedNCT00912977
What this trial is testing

Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 10
Large-scale testing (Phase 3)Study completedNCT02240030
What this trial is testing

Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 351
Post-approval studies (Phase 4)Ended earlyNCT00477802
What this trial is testing

Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Cincinnati 8
Testing effectiveness (Phase 2)Study completedNCT01026428
What this trial is testing

Assess the Effect of Safinamide on Levodopa Pharmacokinetics

Who this might be right for
Idiopathic Parkinson's Disease
Newron Pharmaceuticals SPA 24
Early research (Phase 1)Study completedNCT03065192
What this trial is testing

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's DiseaseParkinson's DiseaseBasal Ganglia Disease+6 more
Neurocrine Biosciences 16
Large-scale testing (Phase 3)Study completedNCT02549092
What this trial is testing

Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)

Who this might be right for
Advanced Parkinson's Disease
AbbVie 89
Early research (Phase 1)Study completedNCT00505843
What this trial is testing

MK0657 in Parkinson's Disease Patients (0657-006)

Who this might be right for
Parkinson's Disease
Merck Sharp & Dohme LLC 18
Load More Results